Characterization of a GH Family 43 β-Xylosidase Having a Novel Carbohydrate-binding Module from

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. A Cold- and Salt-Tolerant GH43-1 β-Xylosidase from Cellulomonas bogoriensis 69B4Applied biochemistry and biotechnology · 2026
   Article
2. Genome-based analyses to learn from and about Paenibacillus sonchi genomovar Riograndensis SBR5T.Genetics and molecular biology · 2024
   Article
3. Diversity and host interaction of the gut microbiota in specific pathogen-free pigs.Frontiers in microbiology · 2024
   Article
4. A C1/C4-Oxidizing AA10 Lytic Polysaccharide Monooxygenase fromJournal of applied glycoscience · 2023
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as